☆ 4.7 Article

Hypoxia-cleavable and specific targeted nanomedicine delivers epigenetic drugs for enhanced treatment of breast cancer and bone metastasis

JOURNAL OF NANOBIOTECHNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Chemistry, Multidisciplinary

Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment

Rui Liu et al.

Summary: Decades have passed since the approval of the first nanoparticles-based medicine for human cancer treatment, and research and development in nanoparticles for drug delivery have been continuing. Today, there have been significant advancements in nanoparticles, including liposomes, solid lipid nanoparticles, inorganic nanoparticles, micelles, nanovaccines, and nano-antibodies. These nanoparticles have shown great potential in the treatment and diagnosis of challenging diseases such as cancer and neurodegenerative diseases, making them promising drug carriers and therapeutic agents in the future.

CHINESE CHEMICAL LETTERS (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA

Joanna Szczepanek et al.

Summary: Breast cancer demonstrates diverse epigenetic abnormalities that impact gene expression and tumor characteristics. Epigenetic alterations are crucial in cancer development and progression, and drugs targeting epigenetic modifications show promise for cancer treatment, including DNA methyltransferase inhibitors, histone-modifying enzymes, and mRNA regulators. However, currently, there is no effective standalone epigenetic drug therapy for breast cancer. Combining epigenetic drugs with conventional therapies has shown positive results, and targeting specific epigenetic changes may lead to more effective monotherapy options in the future.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Review Chemistry, Multidisciplinary

Emerging landscapes of nanosystems based on pre-metastatic microenvironment for cancer theranostics

Yongchao Chu et al.

Summary: The emergence of disseminated metastasis is the leading cause of mortality in patients with malignant tumors. Targeting the pre-metastatic microenvironment may be a promising strategy for preventing metastasis. Nanosystems have shown strong potential in anti-metastatic therapy by selectively targeting pre-metastatic microenvironments.

CHINESE CHEMICAL LETTERS (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Let-7i miRNA and platinum loaded nano-graphene oxide platform for detection/reversion of drug resistance and synergetic chemical-photothermal inhibition of cancer cell

Jianhua Yan et al.

Summary: In this study, a drug delivery system was developed for simultaneous detection/reversion of drug resistance and synergistic chemical-photothermal treatment of ovarian cancer cells. The nano-platform holds great promise in the treatment of drug-resistant cancer cells.

CHINESE CHEMICAL LETTERS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Remodeling cold tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona

Yang He et al.

Summary: There is a close connection between epigenetic regulation, cancer metabolism, and immunology. The combination of epigenetic therapy and immunotherapy provides a promising avenue for cancer management. This study proposes a chemo-free, epigenetic-based combination therapy of panobinostat/JQ1 for metastatic colorectal cancer. The targeted liposomal therapy effectively suppresses the crosstalk between tumor metabolism and immune evasion, providing a potential method for remodeling the tumor immune microenvironment (TIME).

ACTA PHARMACEUTICA SINICA B (2022)

Add to Collection

Review Chemistry, Medicinal

Antiosteoporosis Effects, Pharmacokinetics, and Drug Delivery Systems of Icaritin: Advances and Prospects

Lifang Gao et al.

Summary: This paper focuses on the osteogenic effects and mechanisms, pharmacokinetics and delivery systems of ICT, highlighting bone-targeting strategies.

PHARMACEUTICALS (2022)

Add to Collection

Review Pharmacology & Pharmacy

Cancer bone metastases and nanotechnology-based treatment strategies

Zhaofeng Li et al.

Summary: Bone metastases are recognized as common metastases that affect patient quality of life and survival. Nanomedicine, as a new treatment strategy, shows great potential for the treatment of bone metastases.

EXPERT OPINION ON DRUG DELIVERY (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Co-delivery of anticancer drugs and cell penetrating peptides for improved cancer therapy

Xiao Fu et al.

Summary: The study demonstrated the one-pot synthesis of poly(ethylene glycol) mediated ZIF-8 NPs for the co-delivery of an anticancer drug and a cell-penetrating peptide to improve therapeutic efficacy. These pH-responsive NPs showed stability at neutral pH and released the encapsulated drugs at acidic pH, enhancing their cytotoxicity. This strategy provides a new perspective for the design of drug delivery systems and offers more opportunities for biomedical applications.

CHINESE CHEMICAL LETTERS (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The bone microenvironment invigorates metastatic seeds for further dissemination

Weijie Zhang et al.

Summary: Metastasis is often considered the final step of tumor progression, but recent studies show that many metastases are initiated by the further spread of existing metastases. Through experiments, it was found that the bone microenvironment can facilitate cancer cells to further metastasize and establish secondary metastases in multiple organs. This metastasis-promoting effect is driven by epigenetic reprogramming that confers stem cell-like properties on disseminated cancer cells.

CELL (2021)

Add to Collection

Article Cell Biology

The bone microenvironment increases phenotypic plasticity of ER+ breast cancer cells

Igor L. Bado et al.

Summary: Estrogen receptor-positive (ER+) breast cancer shows strong bone tropism in metastasis, with the bone microenvironment impacting ER signaling and endocrine therapy. The osteogenic niche transiently reduces ER expression and activities specifically in bone micrometastases, leading to endocrine resistance. EZH2-mediated epigenomic reprogramming drives ER+ BMMs towards a basal and stem-like state, and EZH2 inhibition reverses endocrine resistance.

DEVELOPMENTAL CELL (2021)

Add to Collection

Article Pharmacology & Pharmacy

Self-propelled nanomotor reconstructs tumor microenvironment through synergistic hypoxia alleviation and glycolysis inhibition for promoted anti-metastasis

Wenqi Yu et al.

Summary: The study introduces a novel cascade enzyme-powered nanomotor that provides sufficient oxygen and inhibits aerobic glycolysis in deep tumors, effectively alleviating hypoxia and inhibiting tumor metastasis. The nanomotor autonomously moves towards deep tumors, facilitating efficient gene knockdown to inhibit tumor metabolism and metastasis.

ACTA PHARMACEUTICA SINICA B (2021)

Add to Collection

Review Pharmacology & Pharmacy

Integrins as attractive targets for cancer therapeutics

Meng Li et al.

Summary: Integrins are crucial transmembrane receptors involved in various human physiological and pathological processes, particularly in cell interactions and tumor metastasis. Targeting integrins has shown promise in cancer treatment, with integrin antagonists playing a significant role in clinical therapy development.

ACTA PHARMACEUTICA SINICA B (2021)

Add to Collection

Review Pharmacology & Pharmacy

Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages

Wenqi Yu et al.

Summary: Breast cancer is the most common tumor in women and its metastasis increases malignancy and mortality. Nanomedicines have shown great potential in treating cancer metastasis by specifically designed functions at different stages of the process, providing new solutions.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Self-Delivered Supramolecular Nanomedicine with Transformable Shape for Ferrocene-Amplified Photodynamic Therapy of Breast Cancer and Bone Metastases

Yi Qin et al.

Summary: The study developed a self-delivery supramolecular nanoplatform with shape-transforming capacity and enhanced retention effect, which can release ROS in the tumor microenvironment and trigger cascade reactions to alleviate hypoxia and enhance photodynamic therapy efficacy.

ADVANCED FUNCTIONAL MATERIALS (2021)

Add to Collection

Article Cell Biology

The N6-methyladenosine demethylase ALKBH5 negatively regulates the osteogenic differentiation of mesenchymal stem cells through PRMT6

Zhaofeng Li et al.

Summary: This study demonstrates that conditional knockout of the demethylase Alkbh5 in bone marrow mesenchymal stem cells (MSCs) strengthens bone mass in mice, and that ALKBH5 negatively regulates the osteogenic differentiation of MSCs. It also reveals a novel ALKBH5-PRMT6 axis that regulates the osteogenesis of MSCs through activation of the PI3K/AKT pathway.

CELL DEATH & DISEASE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer

Shaokun Shu et al.

MOLECULAR CELL (2020)

Add to Collection

Article Pharmacology & Pharmacy

Bone-seeking nanoplatform co-delivering cisplatin and zoledronate for synergistic therapy of breast cancer bone metastasis and bone resorption

Yanjuan Huang et al.

ACTA PHARMACEUTICA SINICA B (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

HER-2/neu and MYC gene silencing in breast cancer: therapeutic potential and advancement in nonviral nanocarrier systems

Jananee Padayachee et al.

NANOMEDICINE (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

Targeting the epigenetic regulation of antitumour immunity

Simon J. Hogg et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Add to Collection

Article Medicine, General & Internal

Bone metastases

Robert E. Coleman et al.

NATURE REVIEWS DISEASE PRIMERS (2020)

Add to Collection

Review Oncology

Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody

Roger von Moos et al.

CANCER TREATMENT REVIEWS (2019)

Add to Collection

Review Oncology

Bone Metastasis: Find Your Niche and Fit in

Weijie Zhang et al.

TRENDS IN CANCER (2019)

Add to Collection

Review Oncology

BET Proteins as Targets for Anticancer Treatment

Anastasios Stathis et al.

CANCER DISCOVERY (2018)

Add to Collection

Article Chemistry, Multidisciplinary

Bortezomib-catechol conjugated prodrug micelles: combining bone targeting and aryl boronate-based pH-responsive drug release for cancer bone-metastasis therapy

Jianhua Zhu et al.

NANOSCALE (2018)

Add to Collection

Article Chemistry, Multidisciplinary

Bromodomain Drug Discovery - the Past, the Present, and the Future

Mehrosh Pervaiz et al.

CHEMICAL RECORD (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells

Xue Wang et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)

Add to Collection

Review Pharmacology & Pharmacy

Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy

Shu Yang et al.

PHARMACOLOGICAL RESEARCH (2017)

Add to Collection

Article Oncology

Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases

Michael H. Ross et al.

CANCER RESEARCH (2017)

Add to Collection

Article Pharmacology & Pharmacy

Bromodomains: Structure, function and pharmacology of inhibition

Elena Ferri et al.

BIOCHEMICAL PHARMACOLOGY (2016)

Add to Collection

Article Oncology

BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling

Guillaume Andrieu et al.

CANCER RESEARCH (2016)

Add to Collection

Article Multidisciplinary Sciences

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

Shaokun Shu et al.

NATURE (2016)

Add to Collection

Review Pharmacology & Pharmacy

Delivery of epidrugs

Fatima el Bahhaj et al.

DRUG DISCOVERY TODAY (2014)

Add to Collection

Article Multidisciplinary Sciences

Direct measurement of local oxygen concentration in the bone marrow of live animals

Joel A. Spencer et al.

NATURE (2014)

Add to Collection

Article Multidisciplinary Sciences

Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle

Francois Lamoureux et al.

NATURE COMMUNICATIONS (2014)

Add to Collection

Review Oncology

Bone marrow cells in the 'pre-metastatic niche': within bone and beyond

Rosandra N. Kaplan et al.

CANCER AND METASTASIS REVIEWS (2006)

Add to Collection

Article Oncology

Clinical features of metastatic bone disease and risk of skeletal morbidity

Robert E. Coleman

CLINICAL CANCER RESEARCH (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.